Log in or Sign up for Free to view tailored content for your specialty!
Dermatitis News
Adults with atopic dermatitis susceptible to autoimmune diseases
Adults with atopic dermatitis had a higher susceptibility of autoimmune diseases compared with controls, with a significantly higher occurrence in smokers, according to recently published results of a population-based study.
Mortality lower for patients hospitalized for atopic dermatitis compared with psoriasis
Patients who were hospitalized for atopic dermatitis had a significantly lower 10-year mortality compared with patients hospitalized for psoriasis, but an increased mortality compared with the general population, according to recently published study results.
Log in or Sign up for Free to view tailored content for your specialty!
Allergan announces expiration of waiting period for acquisition of Vitae Pharmaceuticals
Allergan and Vitae Pharmaceuticals announced in a press release the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, has expired with respect to Allergan’s proposed acquisition of the clinical stage biotechnology company.
Second Genome, King's College London study eczema, food allergies in infants
Second Genome has announced it is partnering with King’s College London to conduct microbiome profiling and analysis for a study in eczema and food allergies in young children.
TFS acquires German dermatology specialist SCIderm
TFS International has acquired German dermatology specialist SCIderm GmbH, according to a press release.
Psoriasis, atopic dermatitis studies top dermatology reads for week
Study findings on treatments for psoriasis and atopic dermatitis presented at the recent European Academy of Dermatology and Venereology Congress in Vienna were among the most-read articles of the past week on Healio.com/Dermatology.
Developments highlight Eczema Awareness Month
Recent developments in atopic dermatitis and eczema reported on Healio.com/Dermatology highlight Eczema Awareness Month in October.
Dupixent shows efficacy in treating atopic dermatitis
Adults with atopic dermatitis who were treated with Dupixent in two identical phase 3 trials experienced improvement in severity of disease and in symptoms including pruritus, anxiety and depression, according to study results recently published in The New England Journal of Medicine.
Atopic dermatitis negatively impacts patients socially and psychologically, survey reports
Adults with moderate-to-severe atopic dermatitis reported that the disease impacted their lives socially and psychologically, according to survey results.
Alopecia, atopic dermatitis studies top dermatology, aesthetics reads for week
Research presented at Plastic Surgery The Meeting finding that cell-enriched fat may represent an alternative for treating androgenetic alopecia in men and women was among the most-read articles of the past week on Healio.com/Dermatology and Healio.com/Aesthetics.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read